articleThe Lancet Diabetes & EndocrinologySep 21, 2022GREEN OA

Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial

University Health Network · University Medical Center Groningen · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

273
total citations
FWCI
34.19
Percentile
100%
References
44
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Insulin glargine
  • Type 2 diabetes
  • Post-hoc analysis
  • Renal function
  • Internal medicine
  • Diabetes mellitus
  • Population
No related works found for this paper.

Funding